FEIBANF (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the FEIBA drug offered from Baxter Healthcare Corporation. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | Anti-Inhibitor Coagulant Complex |
SUBSTANCE NAME: | |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 1986-01-31 |
END MARKETING DATE: | 0000-00-00 |
FEIBA NF PLASMA DERIVATIVE Details:
Item Description | FEIBA NF from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 1986-01-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64193-223_3bdffc8e-b908-4827-b941-31a1f7063125 |
PRODUCT NDC: | 64193-223 |
APPLICATION NUMBER: | BLA101447 |